Biostar Pharmaceuticals Inc (BSPM)

0.0001 0.00 (0.00%) USD  |  OTCM  |  Apr 18, 16:00
More

Biostar Pharmaceuticals Enterprise Value

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2008. Upgrade now.
Date Value
April 18, 2024 2.062M
April 17, 2024 2.062M
April 16, 2024 2.062M
April 15, 2024 2.062M
April 12, 2024 2.062M
April 11, 2024 2.062M
April 10, 2024 2.062M
April 09, 2024 2.062M
April 08, 2024 2.062M
April 05, 2024 2.062M
April 04, 2024 2.062M
April 03, 2024 2.062M
April 02, 2024 2.062M
April 01, 2024 2.062M
March 28, 2024 2.062M
March 27, 2024 2.062M
March 26, 2024 2.062M
March 25, 2024 2.062M
March 22, 2024 2.062M
March 21, 2024 2.062M
March 20, 2024 2.062M
March 19, 2024 2.062M
March 18, 2024 2.062M
March 15, 2024 2.062M
March 14, 2024 2.062M
Date Value
March 13, 2024 2.062M
March 12, 2024 2.062M
March 11, 2024 2.062M
March 08, 2024 2.062M
March 07, 2024 2.062M
March 06, 2024 2.062M
March 05, 2024 2.062M
March 04, 2024 2.062M
March 01, 2024 2.062M
February 29, 2024 2.062M
February 28, 2024 2.062M
February 27, 2024 2.062M
February 26, 2024 2.062M
February 23, 2024 2.062M
February 22, 2024 2.062M
February 21, 2024 2.062M
February 20, 2024 2.062M
February 16, 2024 2.062M
February 15, 2024 2.062M
February 14, 2024 2.062M
February 13, 2024 2.062M
February 12, 2024 2.062M
February 09, 2024 2.062M
February 08, 2024 2.062M
February 07, 2024 2.062M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

2.062M
Minimum
Dec 31 2021
3.064M
Maximum
Jul 19 2019
2.249M
Average
2.220M
Median
Dec 31 2019

Enterprise Value Benchmarks

American Oriental Bioengineering Inc --
Infinity Pharmaceuticals Inc --
CASI Pharmaceuticals Inc 17.74M
BIMI International Medical Inc 19.66M
Meihua International Medical Technologies Co Ltd --

Enterprise Value Related Metrics

Net Income (Quarterly) -0.1252M
Total Expenses (Quarterly) 0.5734M
EPS Diluted (Quarterly) -0.05